Tectonic Therapeutic | AVRO - Gross Profit On Sales


Tectonic Therapeutic reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 49.21M 13.25M Mar/2025
Alnylam Pharmaceuticals USD 829.31M 219.56M Dec/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
MacroGenics USD 61.25M 88.71M Sep/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Pharma Mar EUR 33.36M 20.25M Sep/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sanofi EUR 8.45B 1.31B Dec/2025
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Takeda JPY 790.55B 262.97B Dec/2025
Tilray USD 67.63M 15.62M Mar/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025